These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35587303)

  • 1. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.
    Muhammed A; Abdelazeem M; Elewa MG; Sharief M; Ammar A
    Heart Fail Rev; 2023 Jan; 28(1):229-240. PubMed ID: 35587303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy.
    De Angelis G; Merlo M; Barbati G; Bertolo S; De Luca A; Ramani F; Adamo L; Sinagra G
    J Am Soc Echocardiogr; 2022 Aug; 35(8):801-809.e3. PubMed ID: 35367610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction.
    Cannatà A; De Angelis G; Boscutti A; Normand C; Artico J; Gentile P; Zecchin M; Heymans S; Merlo M; Sinagra G
    Heart; 2020 May; 106(9):656-664. PubMed ID: 31964657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.
    Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E
    Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse.
    Dognin N; Rimac G; Domain G; Cinq-Mars A; Massot M; Turgeon PY; Dubois-Sénéchal SM; Bourgault C; Morin J; Bernier M; Beaudoin J; Laflamme M; Charbonneau E; Strubé C; Voisine P; Philippon F; Belzile D; Sénéchal M
    Pacing Clin Electrophysiol; 2023 Jul; 46(7):645-656. PubMed ID: 37247219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.
    Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy.
    Pour-Ghaz I; Heckle M; Ifedili I; Kayali S; Nance C; Kabra R; Jha SK; Jefferies JL; Levine YC
    Curr Cardiol Rev; 2022; 18(2):e040821195265. PubMed ID: 34348632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive markers for sudden cardiac death risk stratification in dilated cardiomyopathy.
    Pooranachandran V; Nicolson W; Vali Z; Li X; Ng GA
    Heart; 2022 Jun; 108(13):998-1004. PubMed ID: 34670824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk score to predict the absence of left ventricular reverse remodeling: Implications for the timing of ICD implantation in primary prevention.
    Pérez-Rodon J; Galve E; Pérez-Bocanegra C; Soriano-Sánchez T; Recio-Iglesias J; Domingo-Baldrich E; Alzola-Guevara M; Ferreira-González I; Marsal JR; Ribera-Solé A; Gutierrez García-Moreno L; Cruz-Carlos LM; Rivas-Gandara N; Roca-Luque I; Francisco-Pascual J; Evangelista-Masip A; Moya-Mitjans À; García-Dorado D
    J Cardiol; 2018 May; 71(5):505-512. PubMed ID: 29183646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.
    Halliday BP; Cleland JGF; Goldberger JJ; Prasad SK
    Circulation; 2017 Jul; 136(2):215-231. PubMed ID: 28696268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
    Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit.
    Kolk MZH; Ruipérez-Campillo S; Deb B; Bekkers EJ; Allaart CP; Rogers AJ; Van Der Lingen ACJ; Alvarez Florez L; Isgum I; De Vos BD; Clopton P; Wilde AAM; Knops RE; Narayan SM; Tjong FVY
    Europace; 2023 Aug; 25(9):. PubMed ID: 37712675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy.
    Akhtar M; Elliott PM
    Curr Cardiol Rep; 2019 Nov; 21(12):155. PubMed ID: 31768884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy.
    Goldstein SA; Kennedy KF; Friedman DJ; Al-Khatib SM; Wang A
    J Am Heart Assoc; 2023 Aug; 12(16):e029293. PubMed ID: 37586066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.